Aim To compare the association of metformin use and coronavirus disease 2019 (COVID‐
19) outcomes in a cohort of 31 966 patients with diabetes in Lombardy. Methods We used a …

Type 2 diabetes mellitus (T2DM) is a widespread metabolic condition with a high global
morbidity and mortality rate that affects the whole body. Their primary consequences are …

Diabetes, a chronic metabolic disorder disrupting blood sugar regulation, has emerged as a
prominent silent pandemic. Uncontrolled diabetes predisposes an individual to develop fatal …

The present study aimed to analyse the published data and to realize an update about the
use and pathogenesis of the novel antidiabetic drugs, respectively, dipeptidyl peptidase-4 …

Context Obesity and diabetes are established risk factors for severe SARS-CoV-2 outcomes,
but less is known about their impact on susceptibility to COVID-19 infection and general …

It was previously reported that subjects with diabetes mellitus (DM) are more vulnerable to
several bacterial or viral infections. In the era of coronavirus disease 2019 (COVID-19) …

Aim To evaluate the impact of diabetes and COVID-19 on all-cause-mortality and first
hospitalizations for cardiovascular events (CVE): myocardial infarction or stroke, within six …

There is a scarcity of information on the population with diabetes mellitus type 2 and
cardiomyopathy (PDMC) in COVID-19, especially on the association between anti-diabetic …

Background: SARS-CoV-2 viral infection is a current and important topic for patients with
comorbidities of type 2 diabetes and obesity, associated with increased risk of mortality and …

Since the outbreak of coronavirus disease (COVID-19) in Wuhan, China, triggered by severe
acute respiratory coronavirus 2 (SARS-CoV-2) in late November 2019, spreading to more …